TMO vs LH Stock Comparison

Thermo Fisher Scientific and Labcorp Holdings Prices as of Nov 13, 2026 Peers: Industry group
LH Labcorp Holdings Inc.
$370.59 +16.7% 1M +38.3% 1Y
Market cap
$30.09B
P/E
29.9x
Revenue (TTM)
$14.59B
Div. yield
0.78%
Diagnostic Labs Healthcare
8 wins

Head to Head

12 decided of 12

Labcorp Holdings leads on 8 of the 12 questions below (Labcorp Holdings 8, Thermo Fisher Scientific 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionTMOLHLeader
Larger companyMarket capitalisation $259.44B $30.09B TMO
Cheaper on earningsLower P/E, profitable companies only 36.6x 29.9x LH
Cheaper on forward earningsLower price / next fiscal year consensus EPS 27.0x 21.5x LH
Faster revenue growthRevenue growth, trailing twelve months +8.3% +6.0% TMO
More profitableNet margin, trailing twelve months 14.9% 6.9% TMO
Better return on capitalReturn on invested capital 8.0% 8.3% LH
Less leveragedLower net debt / EBITDA 3.1x 2.6x LH
Higher dividend yieldTrailing dividend yield 0.26% 0.78% LH
Better 1-year returnPrice return, last 12 months +20.7% +38.3% LH
Better 5-year returnAnnualised price return, 5 years +2.0%/yr +7.7%/yr LH
Less volatileAnnualised volatility, 1 year 30.7% 24.1% LH
Higher overall scoreMean of the five percentile scores vs peers 60/100 57/100 TMO

Percentile Scorecard

TMOLH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisTMOLH
Valuation 62 #94 of 243 55 #45 of 99
Growth 41 #136 of 228 36 #57 of 89
Profitability 82 #40 of 222 71 #27 of 92
Financial Health 31 #172 of 248 46 #56 of 103
Shareholder Returns 82 #29 of 158 77 #15 of 63
Overall 60 57
  • TMO ranked among 252 companies in Medical Devices and Diagnostics
  • LH ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodTMOLHSPY
1 month +4.0%+16.7% -2.0%
3 months +19.1%+16.5% -2.8%
6 months +59.7%+48.0% +2.0%
Year to date +20.8%+47.7% +10.6%
1 year +20.7%+38.3% +12.2%
3 years +52.5%+78.1% +68.1%
3 years, per year +15.1%+21.2% +18.9%
5 years +10.2%+45.1% +61.4%
5 years, per year +2.0%+7.7% +10.1%
10 years +362.9%+245.6% +248.5%
10 years, per year +16.6%+13.2% +13.3%

Risk

MeasureTMOLHSPY
Volatility, 1Y 30.7%24.1% 13.6%
Downside volatility, 1Y 29.2%21.5% 13.9%
Beta vs S&P 500, 1Y 0.710.38 1.00
Return / volatility, 1Y 0.671.59 0.90
Max drawdown, 5Y -41.5%-35.0% -25.4%
From 52-week high -3.0%-0.5% -3.2%
52-week high $721.63$372.35 $779.14
52-week low $438.34$250.39 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleTMOLH
P/E now vs peer median 36.6xmedian 26.5x 29.9xmedian 22.4x
P/S now vs peer median 5.5xmedian 2.7x 2.1xmedian 1.3x
EV/EBITDA now vs peer median 25.5xmedian 18.4x 16.2xmedian 14.2x
P/FCF now vs peer median 34.2xmedian 25.4x 23.4xmedian 19.0x
P/B now vs peer median 4.7xmedian 2.5x 3.4xmedian 2.6x
PEG now vs peer median 4.84median 0.98 1.72median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsTMOLH
Revenue $47.35B $14.59B
Gross profit $19.45B $4.23B
Operating income $8.47B $1.50B
Net income $7.09B $1.00B
Free cash flow $7.60B $1.29B
R&D $1.40B –
EPS (diluted) $19.06 $12.30
Cash & equivalents $5.46B $261.80M
Total debt $41.37B $6.03B
Shares (diluted) 371.00M 81.60M
Enterprise value $236.08B $28.19B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricTMOLH
P/E 36.6x 29.9x
P/FCF 34.2x 23.4x
P/Operating cash flow 27.8x 16.6x
P/S 5.5x 2.1x
P/B 4.7x 3.4x
P/Tangible book 7.1x 5.9x
EV/EBITDA 25.5x 16.2x
EV/EBIT 34.8x 23.9x
EV/Revenue 6.2x 2.5x
EV/FCF 38.8x 27.9x
EV/Operating cash flow 31.6x 19.8x
PEG (3Y EPS CAGR) 4.84 1.72

Growth

14 metrics
MetricTMOLH
Revenue growth (1Y) 8.3% 6.0%
Revenue CAGR (3Y) 2.9% 6.6%
Gross profit growth (1Y) 7.8% 8.0%
Gross profit CAGR (3Y) 4.0% 8.2%
Operating income growth (1Y) 12.8% 12.6%
Operating income CAGR (3Y) 7.2% 19.7%
Net income growth (1Y) 7.9% 17.4%
Net income CAGR (3Y) 6.2% 14.9%
EPS growth (1Y) 9.7% 20.4%
EPS CAGR (3Y) 7.6% 17.4%
Operating cash flow growth (1Y) 21.9% 0.6%
Operating cash flow CAGR (3Y) 4.5% 9.0%
Free cash flow growth (1Y) 24.3% -6.8%
Free cash flow CAGR (3Y) 5.1% 8.2%

Profitability

14 metrics
MetricTMOLH
Gross margin 41.1% 29.0%
EBITDA margin 24.4% 15.1%
Operating margin 17.9% 10.3%
Pretax margin 16.7% 8.4%
Net margin 14.9% 6.9%
FCF margin 16.0% 8.8%
Operating cash flow margin 19.7% 12.4%
Return on equity 13.2% 11.5%
Return on assets 6.2% 5.4%
Return on invested capital 8.0% 8.3%
Return on capital employed 8.5% 9.4%
Asset turnover 0.4x 0.8x
Cash conversion (OCF / net income) 1.3x 1.8x
Stock comp / revenue 0.7% 0.9%

Financial Health

11 metrics
MetricTMOLH
Debt / assets 36.2% 31.9%
Debt / equity 0.8x 0.7x
Net debt / EBITDA 3.1x 2.6x
Debt / FCF 5.4x 4.7x
Liabilities / assets 52.1% 53.2%
Equity / assets 47.9% 46.8%
Interest coverage 12.0x 6.5x
Current ratio 1.8x 1.4x
Quick ratio 1.2x 1.0x
Cash ratio 0.4x 0.1x
Altman Z-score 4.18 3.56

Shareholder Returns

7 metrics
MetricTMOLH
Dividend yield 0.3% 0.8%
Net buyback yield 1.6% 2.0%
Shareholder yield 1.8% 2.7%
Payout ratio (earnings) 9.5% –
Payout ratio (FCF) 8.9% –
Dividend growth (1Y) 8.0% –
Dividend CAGR (3Y) 10.1% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusTMOLH
Forward P/E 27.0xFY2026 21.5xFY2026
EPS, next fiscal year $25.92FY2026 $17.22FY2026
EPS growth, next FY +13.3%FY2026 +4.7%FY2026
EPS growth, the year after +2.2% +7.8%
Revenue, next fiscal year $50.12BFY2026 $14.39BFY2026
Revenue growth, next FY +12.5%FY2026 +3.1%FY2026
Revenue growth, the year after -2.7% +12.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersTMOLH
Held by institutions 90.2% 97.0%
Institutions holding 2,627 1,053
Change in shares held, QoQ +0.8% +1.6%
Institutions buying 1,145 466
Institutions selling 1,145 393
Buyers to sellers 1.00 1.19

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

TMOLH
TMO 1.00 0.45
LH 0.45 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, TMO and LH?

Thermo Fisher Scientific (TMO) is the largest by market capitalisation: Thermo Fisher Scientific (TMO) $259.44B, Labcorp Holdings (LH) $30.09B.

Which stock is cheaper, TMO and LH?

Labcorp Holdings (LH) trades on the lowest price-to-earnings ratio (Thermo Fisher Scientific (TMO) 36.6x, Labcorp Holdings (LH) 29.9x). On next year's consensus earnings, Labcorp Holdings (LH) is cheapest (Thermo Fisher Scientific (TMO) 27.0x, Labcorp Holdings (LH) 21.5x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Thermo Fisher Scientific (TMO) grew revenue fastest over the trailing twelve months: Thermo Fisher Scientific (TMO) +8.3%, Labcorp Holdings (LH) +6.0%.

Which company is more profitable?

Thermo Fisher Scientific (TMO) has the highest net margin (Thermo Fisher Scientific (TMO) 14.9%, Labcorp Holdings (LH) 6.9%). On return on invested capital, Labcorp Holdings (LH) leads (Thermo Fisher Scientific (TMO) 8.0%, Labcorp Holdings (LH) 8.3%).

Which stock has performed better?

Over the past year Labcorp Holdings (LH) returned the most: Thermo Fisher Scientific (TMO) +20.7%, Labcorp Holdings (LH) +38.3%. Over five years, Labcorp Holdings (LH) compounded fastest (Thermo Fisher Scientific (TMO) +2.0%/yr, Labcorp Holdings (LH) +7.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Labcorp Holdings (LH) has the highest dividend yield: Thermo Fisher Scientific (TMO) 0.26%, Labcorp Holdings (LH) 0.78%.

Which stock is riskier?

By one-year price volatility, Labcorp Holdings (LH) has been the steadiest (Thermo Fisher Scientific (TMO) 30.7%, Labcorp Holdings (LH) 24.1%). Volatility measures how widely the price swings, not the risk of the business.

Do TMO and LH move together?

Their daily returns over the past year have a correlation of 0.45, a moderate positive relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, TMO and LH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Labcorp Holdings (LH) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.